Serum concentration of zinc is elevated in clinically stable bipolar disorder patients.
C-reactive protein
bipolar patients
cognition
serum
zinc
Journal
Brain and behavior
ISSN: 2162-3279
Titre abrégé: Brain Behav
Pays: United States
ID NLM: 101570837
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
revised:
06
11
2021
received:
04
07
2021
accepted:
01
12
2021
pubmed:
31
12
2021
medline:
15
3
2022
entrez:
30
12
2021
Statut:
ppublish
Résumé
Bipolar disorder (BD) is a chronic psychiatric disorder characterized by recurrent mood episodes interspersed with euthymic periods. A growing number of studies have indicated that zinc plays an important role in coordinating immune responses, as well as being involved in synaptic transmission. In the current study, we set out to measure serum levels of zinc in a meticulously phenotyped cohort of 121 euthymic BD subjects and 30 matched controls. Serum levels of zinc were measured by photometry. To assess the interplay between zinc levels and immune activation in BD, we measured serum levels of high-sensitive C-reactive protein (hsCRP) levels by immunoturbidimetric assay, and serum levels of monocyte chemoattractant protein-1 (MCP-1), chitinase 3-like protein 1 (YKL-40), and soluble cluster of differentiation 14 (sCD14) by electrochemiluminescence enzyme-linked immunosorbent assays. The baseline clinical diagnostic instrument for BD was the Affective Disorder Evaluation, and executive functioning was assessed by using the Delis-Kaplan Executive Function System. Controlling for potential confounding factors, BD patients displayed increased serum levels of zinc unrelated to hsCRP, MCP-1, YKL-40, and sCD14 levels. Serum levels of zinc did not associate with executive functioning or measurements of disease severity. This study suggests that the zinc homeostasis is disturbed in BD and that this dyshomeostasis is not related to ongoing mood symptoms or immune activation. Of note, serum levels were increased and hence do not support continuous zinc supplementation in BD.
Sections du résumé
BACKGROUND
Bipolar disorder (BD) is a chronic psychiatric disorder characterized by recurrent mood episodes interspersed with euthymic periods. A growing number of studies have indicated that zinc plays an important role in coordinating immune responses, as well as being involved in synaptic transmission. In the current study, we set out to measure serum levels of zinc in a meticulously phenotyped cohort of 121 euthymic BD subjects and 30 matched controls.
METHODS
Serum levels of zinc were measured by photometry. To assess the interplay between zinc levels and immune activation in BD, we measured serum levels of high-sensitive C-reactive protein (hsCRP) levels by immunoturbidimetric assay, and serum levels of monocyte chemoattractant protein-1 (MCP-1), chitinase 3-like protein 1 (YKL-40), and soluble cluster of differentiation 14 (sCD14) by electrochemiluminescence enzyme-linked immunosorbent assays. The baseline clinical diagnostic instrument for BD was the Affective Disorder Evaluation, and executive functioning was assessed by using the Delis-Kaplan Executive Function System.
RESULTS
Controlling for potential confounding factors, BD patients displayed increased serum levels of zinc unrelated to hsCRP, MCP-1, YKL-40, and sCD14 levels. Serum levels of zinc did not associate with executive functioning or measurements of disease severity.
DISCUSSION
This study suggests that the zinc homeostasis is disturbed in BD and that this dyshomeostasis is not related to ongoing mood symptoms or immune activation. Of note, serum levels were increased and hence do not support continuous zinc supplementation in BD.
Identifiants
pubmed: 34967503
doi: 10.1002/brb3.2472
pmc: PMC8785612
doi:
Substances chimiques
C-Reactive Protein
9007-41-4
Zinc
J41CSQ7QDS
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2472Informations de copyright
© 2021 The Authors. Brain and Behavior published by Wiley Periodicals LLC.
Références
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
J Proteome Res. 2006 Jan;5(1):196-201
pubmed: 16396512
Bipolar Disord. 2018 May;20(3):228-237
pubmed: 29121444
Nat Rev Neurosci. 2005 Jun;6(6):449-62
pubmed: 15891778
Br J Psychiatry. 1978 Nov;133:429-35
pubmed: 728692
Curr Neuropharmacol. 2015;13(4):505-13
pubmed: 26412070
Br J Psychiatry. 1979 Apr;134:382-9
pubmed: 444788
Psychiatry Res. 2019 Aug;278:180-187
pubmed: 31207455
Psychiatry Res. 2017 Sep;255:52-58
pubmed: 28528241
Bull Menninger Clin. 1975 Sep;39(5):448-80
pubmed: 1182328
Front Psychiatry. 2020 Feb 26;11:71
pubmed: 32174850
Neuron. 2000 Dec;28(3):911-25
pubmed: 11163276
Acta Psychiatr Scand. 2010 Dec;122(6):499-506
pubmed: 20637012
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Aug 4;53:23-34
pubmed: 24468642
Nat Rev Neurosci. 2009 Nov;10(11):780-91
pubmed: 19826435
Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
Lancet Psychiatry. 2016 Dec;3(12):1147-1156
pubmed: 27838212
Mol Psychiatry. 2016 Oct;21(10):1342-50
pubmed: 26666201
J Immunol Res. 2016;2016:6762343
pubmed: 27872866
Neuron. 2000 Apr;26(1):187-96
pubmed: 10798403
Nat Neurosci. 2011 Jul 03;14(8):1017-22
pubmed: 21725314
PLoS One. 2015 Jan 23;10(1):e0115562
pubmed: 25614986
Brain Behav Immun. 2017 Oct;65:195-201
pubmed: 28483660
J Psychiatry Neurosci. 2015 Jul;40(4):250-8
pubmed: 25768030
J Trace Elem Med Biol. 2020 May;59:126467
pubmed: 31954929
Biol Psychiatry. 2013 Dec 15;74(12):872-8
pubmed: 23806573
Science. 1994 Sep 2;265(5177):1464-7
pubmed: 8073293
J Trace Elem Med Biol. 2011 Jan;25 Suppl 1:S78-83
pubmed: 21242074
Brain Behav. 2022 Jan;12(1):e2472
pubmed: 34967503
Psychiatry Res. 2018 Mar;261:383-390
pubmed: 29353768
Adv Nutr. 2013 Mar 01;4(2):176-90
pubmed: 23493534
Brain Behav Immun. 2020 Aug;88:870-877
pubmed: 32278851
Biol Psychiatry. 2020 Feb 1;87(3):271-281
pubmed: 31635761
Nat Genet. 2019 May;51(5):793-803
pubmed: 31043756
Eur Addict Res. 2005;11(1):22-31
pubmed: 15608468
Biol Psychiatry. 2003 Jun 1;53(11):1028-42
pubmed: 12788248
J Affect Disord. 2016 Jan 15;190:272-277
pubmed: 26540081
J Neurosci. 1997 Aug 1;17(15):5711-25
pubmed: 9221770
Physiol Rev. 1993 Jan;73(1):79-118
pubmed: 8419966
Eur J Clin Nutr. 2015 Jun;69(6):649-61
pubmed: 25920424
Gen Hosp Psychiatry. 2020 Aug 10;:
pubmed: 32829928
J Affect Disord. 2016 Nov 15;205:165-181
pubmed: 27449549
J Affect Disord. 2016 Sep 01;201:88-94
pubmed: 27182964
Transl Psychiatry. 2019 Jan 29;9(1):37
pubmed: 30696814